Directly measure proteins that are truly accessible on the tumor cell surface, enabling confident target identification.
Directly measure phosphorylation-driven signaling activity in human tumors to characterize functional pathway activation.
Directly measure immune cell states & signaling pathways in human tumors to characterize immune activity & response.
Directly measure protein networks that drive therapeutic resistance in human tumors to characterize resistance mechanisms.
See how DynamiQ transforms the pace & precision of drug development by grounding every insight in real‑world human biology.
Measure proteins & PTMs directly, at scale – covering 5,400+ proteins in plasma and 12,000+ in tissue matrices.
Gain an unprecedented view into dynamic factors that modulate health, disease pathobiology & drug response.
Measure the proteins that matter most to your study – precisely, quantitatively, and at scale.
How our comprehensive library of 13,000+ reference standards enhances the speed, quality & extent of metabolite identification.
This panel offers highly sensitive multiplexed analysis of 220 biomarkers considered the hallmarks of neurodegenerative diseases.
Enabling absolute quantitation of APOE4, BD-pTau217, Aβ42, GFAP, and NfL in a single multiplexed assay.
See how we decipher the heterogeneity in disease biology and patient response by integrating multiple layers of molecular data.
